Evarab-DSR Capsule is a combination medication containing Domperidone 30mg and Rabeprazole 20mg, designed to effectively manage gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastric motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Rabeprazole, a proton pump inhibitor, works by suppressing gastric acid secretion, providing relief from acid-related conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The synergistic action of these two components makes Evarab-DSR Capsule particularly useful in treating conditions characterized by delayed gastric emptying accompanied by excessive acid production. It is commonly prescribed for patients experiencing heartburn, acid reflux, indigestion, and related discomforts. The capsule should be taken as directed by a healthcare professional, usually before meals, to maximize its therapeutic effects. Patients with known hypersensitivity to either component, severe liver impairment, or certain cardiac conditions should use this medication cautiously. Common side effects may include headache, dry mouth, or abdominal cramps, but these are generally mild and transient. Evarab-DSR Capsule offers a comprehensive approach to managing upper gastrointestinal symptoms, improving patient comfort and quality of life.